BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
TGFB1
,
glucose metabolic process
,
Inflammatory disorder
,
Neuron
,
Autoimmunity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
bullous pemphigoid antigen 1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Substantia nigra reticulata
Substantia nigra pars compacta
Corpus callosum
Globus pallidum external
Midbrain
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Dystonin modifiers of junctional epidermolysis bullosa and models of epidermolysis bullosa simplex w…
Characterization of gastrointestinal pathologies in the dystonia musculorum mouse model for heredita…
The DST gene in neurobiology.
Postoperative Complications of Surgery for Cervical Spondylotic Myelopathy with and Without Athetoid…
Dystonin loss-of-function leads to impaired autophagosome-endolysosome pathway dynamics.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Genetic Susceptibility and Influence of the Microbiomae in Bullous Pemphigoid
Ixekizumab in the Treatment of Bullous Pemphigoid
Bullous Pemphigoid Induced by antiPD-1/PDL-1 Therapy
A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid.
Anti-IL-5 Therapy in Bullous Pemphigoid (BP)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ